skip to main content

News Archive

Date: 02/03/2022
A team of interdisciplinary researchers at the University of Michigan, backed by a $1 million W.M. Keck Foundation grant, has developed a high-risk, high-reward approach to understand how each cell in a population processes information and translates that to action driving cancer cell progression.
Date: 01/28/2022
Hyaluronic acid, or HA, is a known presence in pancreatic tumors, but a new study from researchers at Rogel Cancer Center shows that hyaluronic acid also acts as food to the cancer cells. These findings, recently published in eLife, provide insight into how pancreatic cancer cells grow and indicate new possibilities to treat them.
Date: 01/27/2022
The University of Michigan Rogel Cancer Center is home to seven members selected as 2021 fellows of the American Association for the Advancement of Science. These Rogel Cancer Center researchers are among 564 scientists, engineers and innovators spanning 24 scientific disciplines, recognized for their scientifically and socially distinguished achievements.
Date: 01/20/2022
The University of Michigan Health Rogel Cancer Center has named David C. Smith, M.D., chief medical officer and associate director for cancer clinical services, and Shruti Jolly, M.D., associate director for the Michigan Medicine statewide cancer network.
Date: 01/19/2022
A mutated gene affects growth of brain tumor cells in young adults, indicating sensitivity to a new treatment strategy, a team of researchers at the Rogel Cancer Center discovered. These findings, recently published in Cell Reports, present possibilities for more effective therapies for glioma patients with this gene mutation.
Date: 01/13/2022
A $7.6 million gift from Judith L. Tam and the Richard Tam Foundation has launched an accelerated research initiative here at the Rogel Cancer Center to understand why alterations in the ALK gene causes lung cancer to become resistant to standard therapy over time.
Date: 12/17/2021
The Ronald Weiser Center for Prostate Cancer will aim to elevate and optimize the health care experience for patients with prostate cancer and their families.
Date: 12/03/2021
Inside our cells is a complex networks of signals, proteins that need to get to the right place at the right time. And to get there, many rely on a type of protein called kinesins. A study led by the University of Michigan has uncovered unexpected details about a key regulator of this cellular traffic.
Date: 12/03/2021
The University of Michigan Health Rogel Cancer Center has earned a three-year accreditation from the National Accreditation Program for Rectal Cancer, a quality program of the American College of Surgeons’ Commission on Cancer. This recognition signals advanced technical expertise and multidisciplinary care for rectal cancer.
Date: 12/03/2021
The 63rd American Society of Hematology Annual Meeting and Exposition runs Dec. 11-14, 2021, both in-person in Atlanta, Georgia, and virtually. Rogel Cancer Center members will present about 30 sessions, beginning with pre-conference workshops on Dec. 8.